In a year already marked by headlines of Ebola outbreaks and flashback-inducing cruise ship quarantines, everyday foodborne threats are delivering a sharp reminder of supply chain vulnerability. Since May, an ongoing cyclosporiasis outbreak that may be linked to contaminated Mexican iceberg lettuce has caused over 1,600 confirmed cases and prompted multi-state recalls.
Portfolios are commonly underexposed to the companies driving healthcare innovation. As technological disruptions build across medical fields, the ROBO Global Healthcare Technology and Innovation ETF (HTEC) provides targeted exposure to the global value chain driving this high-growth opportunity.
The artificial intelligence and robotics investment opportunity extends far beyond the headline-grabbing tech giants, offering exposure to a diverse ecosystem of enablers and application developers that many investors overlook, according to experts at VettaFi's Winter Symposium on Thursday.
Healthcare technology continues to offer a powerful combination of health care investing durability and tech innovation upside. In an uncertain market, the segment can often prove a reliable source of performance for portfolios.
Looking for ETFs with a strong case for upside this year? With many investors wary of concentration risk, now could be the time to diversify into other exciting areas.